Sunway Healthcare Group Partners with Syneos Health to Enhance Clinical Trials in Malaysia
Sunway Healthcare Group is excited to announce its partnership with Syneos Health®, a leading organisation specialising in comprehensive biopharmaceutical solutions. This collaboration represents a significant step forward in expanding clinical trial capabilities across a wider array of therapeutic areas in Malaysia.
As the first private hospital network in Malaysia to join Syneos Health’s Catalyst and Site Network Partnerships program, Sunway Healthcare Group is now part of an exclusive network that includes over 110 clinical sites and 60 commercial site networks worldwide. This partnership aligns Sunway Healthcare Group with Syneos Health’s high-performing investigative site networks, providing access to improved patient recruitment, specialised expertise, greater efficiencies, and diverse patient populations across all therapeutic areas and phases of clinical studies.
“We are proud to be the first private hospital network to join Syneos Health’s partnership program, emphasising our commitment to prioritising our patients’ well-being. Each clinical trial we conduct aims to bring innovative therapies closer to those in need, offering hope and improved access to treatment. Through this collaboration, we look forward to making these therapies available to our community, ultimately enhancing health outcomes for our patients,” said Dr. Khoo Chow Huat, Managing Director of Sunway Healthcare Group.
“We are thrilled to partner with Sunway Healthcare Group. This venture solidifies our commitment to developing a longstanding and productive partnership to reduce the time from lab to life and improve access to clinical trials in Malaysia,” said Serena Chan, Vice President of Clinical Operations and General Manager of SEA at Syneos Health. “This collaboration is focused on maintaining consistent quality and efficient delivery of clinical trials to accelerate therapy development for patients.”
This partnership underscores Sunway Healthcare Group’s unwavering dedication to conducting high-quality clinical trials and enhancing patient outcomes.
For more information, please contact the Sunway Clinical Research Centre at 03-8601 1080 or email [email protected].
